Weber et al. Flow-controlled ventilation improves oxygenation in mechanically ventilated lung-healthy patients – a crossover controlled interventional trial. Abstract #3301 presented at Euroanaesthesia 2019 – Manuscript submitted
The workgroup of Prof. Schumann revealed in a crossover randomized controlled trial in lung-healthy patients a higher efficiency of ventilation when using FCV® compared to VCV, even after short-term application. With similar ventilation settings, FCV® resulted in a 9% higher arterial oxygenation and 4% lower arterial CO2 concentration (P<0.001). The mean tracheal pressure was higher during FCV® (+10 %; P<0.001). This study indicates that
FCV® may help to prevent hypoxemia during mechanical ventilation.
Get back to Literature
Hamad Medical Corporation (HMC) Qatar, has introduced our ventilator Evone in their daily clinical practice, being the first in the Middle East. We congratulate the anesthesiology team led by Prof. Dr. Marco Marcus with regional recognition of their fantastic...